In this study, we developed a novel theranostic nanomedicine formulation that integrates multimodal imaging with controlled drug release in reactive oxygen species (ROS)-rich microenvironments. A fluorinated oxalate compound (FOC) was synthesized through a one-step condensation reaction between 1,1,1,3,3,3-hexafluoro-2-propanol and oxalyl chloride, characterized by 1H, 13C, and 1⁹F NMR spectroscopy. The FOC and luminophore-incorporated nanomedicine formulations reacted rapidly with hydrogen peroxide via the peroxyoxalate chemiluminescence (POCL) mechanism, producing strong chemiluminescence and inducing a notable 19-fold increase in ratiometric 1⁹F NMR signal upon conversion to fluorinated alcohol (FAH), demonstrating promising potential for high-contrast 1⁹F MRI in deep tissue. Following ROS stimulation, the chemical conversion from hydrophobic FOC to hydrophilic FAH led to the degradation of the nanomedicines, facilitating payload release. In vitro experiments with A-431 cancer cells under hypoxic conditions confirmed ROS-responsive drug release, evidenced by enhanced fluorescence from model luminophores. Additionally, doxorubicin-loaded FOC nanomedicines reduced cell viability to 32% under hypoxia while remaining non-toxic in normoxic conditions. These results indicate that FOC-based nanomedicine formulations provide a promising platform for combined chemiluminescence and 1⁹F MRI with targeted therapeutic efficacy in ROS-rich inflammatory and cancerous tissues.
18 December 2024 in European Journal of Organic Chemistry
A silver(I) triflate-catalyzed post-Ugi assembly of novel pyrazolo[1,5-a][1,4]diazepine scaffolds is reported offering high yields (up to 98%) under mild conditions. The synthetic sequence involves the Ugi four-component reaction (U4CR) of pyrazole-3-carbaldehydes, primary amines, 3-substituted propiolic acids, and isocyanides, followed by a silver(I) triflate-catalyzed intramolecular heteroannulation of the resulting pyrazole-tethered propargylamides occurring in a 7-endo-dig fashion. The approach is scalable and tolerates a diverse range of substitution patterns.
8 February 2026 in The Journal of Organic Chemistry
Single-phase white-light-emitting materials, particularly 2D hybrid organic–inorganic halide perovskites, have garnered significant attention due to their strong electron–phonon interactions, which lead to broad luminescence and a notable Stokes shift resulting from self-trapped exciton recombination. However, 2D lead iodide perovskites typically display these characteristics poorly, restricting their efficiency as white-light emitters. This study presents a 2D lead iodide perovskite that incorporates a fluorinated π-conjugated aggregation-induced enhanced emission luminophore, FPCSA, as a bulky organic cation to create a quasi-2D perovskite. The FPCSA cation establishes a Type II energy level alignment with the lead iodide layer in the 2D perovskite, and a significant energy offset effectively suppresses charge transfer, enabling independent emission from both the organic and inorganic layers while facilitating self-trapped exciton formation. Under 315 nm UV excitation, this material demonstrates warm white-light emission with RGB triple-band photoluminescence stemming from the electronically decoupled FPCSA and perovskite layers. These findings provide a promising new method for designing efficient single-phase white-light-emitting materials for optoelectronic applications.
A diastereoselective approach to sp 3 -enriched tetrahydroisoquinolines from Ugi-derived propargylamides via a sequence of Pd-catalyzed reductive Heck cyclization and heterogeneous double-bond hydrogenation is reported.